Full Record Display for the EPA National Library Catalog


Main Title Economic impact and regulatory flexibility analysis of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report.
CORP Author Environmental Protection Agency, Washington, DC. Engineering and Analysis Div.
Publisher U.S. Environmental Protection Agency, Office of Water, Office of Science and Technology, Engineering and Analysis Division,
Year Published 1995
Report Number EPA 821-R-95-018
Stock Number PB95-219010
OCLC Number 32655298
Subjects Effluent quality--Standards--Compliance costs ; Pharmaceutical industry--Environmental aspects--United States ; Pharmaceutical industry--United States--Environmental aspects
Additional Subjects Drug industry ; Water pollution control ; Economic impact ; Waste water treatment ; Industrial waste treatment ; Facilities management ; Operation and maintenance ; Chemical effluents ; Water pollution standards ; Standards compliance ; Pollution regulations ; Requirements ; Water pollution economics ; Cost analysis ; Employment ; Prices ; Profits ; Closures ; Small businesses ; Economic analysis ; Market analysis ; Pharmaceutical manufacturing ; Regulatory Flexibility Act
Internet Access
Description Access URL
Library Call Number Additional Info Location Last
EJAD  EPA 821/R-95-018 Region 3 Library/Philadelphia, PA 07/21/1995
EJED  EPA 821-R-95-018 OCSPP Chemical Library/Washington,DC 12/31/1998
ELBD ARCHIVE EPA 821-R-95-018 Received from HQ AWBERC Library/Cincinnati,OH 10/04/2023
ELBD  EPA 821-R-95-018 AWBERC Library/Cincinnati,OH 01/24/2017
NTIS  PB95-219010 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 1 volume (various pagings) : illustrations ; 28 cm
Abstract The economic impact analysis (EIA) examines compliance costs and economic impacts resulting from the U.S. Environmental Protection Agency's (EPA's) proposed revisions to effluent guidelines for the U.S. pharmaceutical industry. The EIA estimates the economic effects of compliance with the proposed regulation in terms of annualized costs; facility closures; changes in rate of return on assets and the interest coverage ratio at the firm level; and profitability effects at the firm level. In addition, impacts on employment and affected communities, foreign trade, specific demographic groups, and new sources also are considered. Finally, a Regulatory Flexibility Analysis detailing the impacts on small businesses within the pharmaceutical industry is included in the EIA.
Notes "February 1995." Includes bibliographical references. "EPA 821-R-95-018"--Cover.
Place Published Washington, DC
Corporate Au Added Ent United States. Environmental Protection Agency. Office of Science and Technology. Engineering and Analysis Division.
PUB Date Free Form 1995
NTIS Prices PC A14/MF A03
BIB Level m
Medium unmediated
Content text
Carrier volume
Cataloging Source OCLC/T
OCLC Time Stamp 20170118061903
Language eng
Origin OCLC
OCLC Rec Leader 01656cam 2200397Ka 45010